Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,428.00
Bid: 12,432.00
Ask: 12,436.00
Change: -82.00 (-0.66%)
Spread: 4.00 (0.032%)
Open: 12,556.00
High: 12,562.00
Low: 12,420.00
Prev. Close: 12,510.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Currency markets stay 'risk-on' as dollar hits lowest since 2018

Wed, 30th Dec 2020 12:33

* Dollar falls to lowest since April 2018

* Pound boosted by UK Oxford/AstraZeneca vaccine approval

* Aussie, Kiwi gain versus dollar

* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E
(Updates throughout, adds virus latest and inflation
expectations)

By Elizabeth Howcroft

LONDON, Dec 30 (Reuters) - The dollar slid to its lowest in
more than two years on Wednesday and riskier currencies gained,
as investors looked past rising COVID-19 infections and the
latest delay in U.S. fiscal stimulus talks to bet on an economic
recovery in 2021.

Lockdown measures in England will be extended, and U.S.
President-elect Joe Biden warned that it could take years for
most Americans to be vaccinated against COVID-19 at current
rates.

U.S. Senate Majority Leader Mitch McConnell on Tuesday
blocked a vote on increasing COVID-19 relief payments to $2,000,
adding another delay to fractious negotiations over fiscal
stimulus.

But market sentiment was upbeat as investors remained
optimistic that a stimulus deal will be eventually reached and
that COVID-19 vaccines will facilitate a global economic
recovery, lessening demand for the safe-haven dollar.

The latest setback "doesn’t really matter too much for
investors, as they have been over the moon on the back of news
that there is still plenty of fiscal support for the U.S.
economy," Naeem Aslam, chief market analyst at Avatrade, said in
a note.

Analysts expect the dollar to weaken further in 2021 as U.S.
President-elect Biden is expected to push for even more measures
to support the U.S. economy.

The "risk-on" moves in currency markets saw major currencies
reach record levels in the Asian session on Wednesday, ease off
as European markets opened, then hit new records as the European
session continued.

At 1159 GMT, the dollar was down around 0.3% versus a basket
of currencies at 89.737, having dropped as low as 89.681 shortly
before 1100 GMT. The euro was up at $1.22715.

The Australian dollar - seen as a liquid proxy for global
risk appetite - was up 0.8% on the day at 0.7664 at 1202 GMT
. The New Zealand dollar also hit two-year highs
.

The dollar lost out to the Japanese yen, with dollar-yen
down 0.4% at 103.13.

In Europe, sentiment was buoyed by Britain becoming the
first country in the world to approve the COVID-19 vaccine
developed by AstraZeneca and Oxford University.

The British pound was up against the dollar at $1.3607, but
little changed against the euro, as traders returning from the
Christmas break digested the Brexit deal struck on Dec. 24.

Although the agreement avoids a chaotic no-deal exit, it
does not cover services, which make up 80% of the British
economy.

Commonwealth Bank of Australia wrote in a note to clients
that the lack of an equivalence framework for financial services
in the deal and growing support for Scottish independence are
new headwinds for the pound.

Euro zone government bond yields edged up by around one to
two basis points, with Germany's benchmark 10-year yield at
-0.562% at 1206 GMT.

There were some signs of increasing inflation expectations.
Breakeven rates on 10-year TIPS, which measure expected annual
inflation for the next decade, slipped to 1.962%.

"The rapid growth in U.S. money supply and rising commodity
prices are stirring up fears about a return of inflation," wrote
Schroders analysts in a note.

"These concerns are reflected in inflation-linked
securities, with the 10-year breakeven inflation rate in the
U.S. having risen from 0.5% in March to just under 2% today,"
they said.

The euro zone's five-year, five-year inflation forward
reached its highest since February earlier in December
.

Elsewhere, Bitcoin reached a record high of $28,599.99,
taking the yearly gain for the world's most popular
cryptocurrency past 295%.

(Reporting by Elizabeth Howcroft; Editing by Larry King and Jan
Harvey)

More News
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.